Experiment: 5IEB

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-13C NOESY aromatic	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE II 900
2	3D 1H-13C NOESY aliphatic	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE II 900
3	3D 1H-15N NOESY	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE II 900
4	3D HNCO	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500
5	3D HNCACB	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500
6	3D CBCA(CO)NH	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500
10	3D H(CCO)NH	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500
9	3D C(CO)NH	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500
8	3D HCCH-TOCSY	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500
11	1D H	1 mM [U-99% 13C; U-99% 15N] SdrG, 10 mM NaPO4, 50 mM NaCl	90% H2O/10% D2O	50 mM	6.5	AMBIENT Pa	303	Bruker AVANCE III 500

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	500
2	Bruker	AVANCE II	900

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	30
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.96	P. Gunther
2	refinement	Amber	12	Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
3	collection	TopSpin	3.2	Bruker Biospin
4	data analysis	CARA		Keller and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.